A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers.

@article{Konoshita2013ACC,
  title={A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers.},
  author={Tadashi Konoshita and Yasukazu Makino and Tomoko Kimura and Miki Fujii and Norihiro Morikawa and Shigeyuki Wakahara and Kenichiro Arakawa and Isao Inoki and Hiroyuki Nakamura and Isamu Miyamori},
  journal={International journal of cardiology},
  year={2013},
  volume={166 2},
  pages={448-52}
}
BACKGROUND At the intervention for cardiovascular disease (CVD), albuminuria is a new pivotal target. Calcium channel blocker (CCB) is one of the most expected agents. Currently CCBs have been classified by delivery system, half-life and channel types. We tested anti-albuminuric effect among 4 types of CCBs. METHODS Subjects were 50 hypertensives (SBP/DBP… CONTINUE READING